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In a recently published study in this journal that used a population-based sample in the Republic of Ireland (Karatzias et al., 2020), we
concluded that 17.7% of the sample met the diagnostic requirements for COVID-19–related posttraumatic stress disorder (PTSD). Sub-
sequently, Van Overmeire (2020) has raised concerns about the validity of our findings, arguing that simply experiencing the COVID-19
pandemic is not sufficient to meet the trauma exposure criterion for a PTSD diagnosis and, consequently, our estimated PTSD prevalence
figure was inflated. In this response, we provide (a) an explanation for why the COVID-19 pandemic can be reasonably considered to be a
traumatic event, (b) evidence that PTSD in response to the COVID-19 pandemic is a meaningful construct, and (c) an argument for why
our estimated prevalence rate is not unreasonably high.
Following the announcement by the World Health Organiza-
tion (WHO) on March 11, 2020, that COVID-19 had reached
pandemic status, our research consortium launched parallel
studies in the Republic of Ireland, the United Kingdom, and
other European and Middle Eastern countries to assess the im-
pact of the pandemic on themental health of the general popula-
tion in these nations. When considering what measures of men-
tal health to use, vigorous discussions took place about whether
posttraumatic stress disorder (PTSD) was a meaningful con-
struct in the context of the COVID-19 pandemic. We concluded
that it was, and we have recently published findings from the
first wave of our study in the Republic of Ireland in this journal
(Karatzias et al., 2020), reporting that 17.7% of a nationally rep-
resentative sample of the general adult population (N = 1,041)
met the diagnostic requirements for PTSD. Subsequently, Van
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Overmeire (2020) has raised concerns about the validity of our
findings, arguing that simply experiencing the COVID-19 pan-
demic is not sufficient to meet the trauma exposure criterion
for a PTSD diagnosis and, consequently, our estimated PTSD
prevalence figure was severely inflated. In this response letter,
we will provide (a) an explanation for why the COVID-19 pan-
demic can be reasonably considered to be a traumatic event, (b)
evidence that PTSD in response to the COVID-19 pandemic is
a meaningful construct, and (c) an argument for why our esti-
mated prevalence rate is not absurdly high.
Van Overmeire (2020) critiqued our study (Karatzias et al.,
2020) on the basis that “the basic requirement for a PTSD diag-
nosis was not fulfilled—namely, a life-threatening or severely
stressful event.” The answer to the question of whether the
COVID-19 pandemic is a valid traumatic event for PTSD de-
pends on the diagnostic lens through which one chooses to view
the COVID-19 pandemic. In the International Classification of
Diseases (11th rev.; ICD-11; WHO, 2018), PTSD is described
as a disorder that can develop “following exposure to an ex-
tremely threatening or horrific event or series of events.” Of
note, ICD-11 also includes complex PTSD (CPTSD) as a re-
lated but distinct disorder that can arise following trauma ex-
posure. Whereas the ICD-11 provides this general guidance on
what constitutes a traumatic event, the Diagnostic and Statis-
tical Manual of Mental Disorders (fifth ed.; DSM-5; American
Psychiatric Association [APA], 2013) provides a more specific
definition in its description of Criterion A, which defines a as
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“exposure to actual or threatened death, serious injury, or sex-
ual violence,” and it can involve (a) “directly experiencing the
traumatic event(s),” (b) “witnessing, in person, the event(s) as
it occurred to others,” (c) “learning that the traumatic event(s)
occurred to a close family member or close friend,” or (d) “ex-
periencing repeated or extreme exposure to aversive details of
the traumatic event(s).” It is important to note that the DSM-5
states that the fourth type of event “does not apply to expo-
sure through electronic media, television, movies, or pictures,
unless this exposure is work-related.” The inclusion of these
descriptions herein is not meant as a tutorial on the nosology
of PTSD; rather we aim to demonstrate the different diagnostic
lenses through which an event may be considered “traumatic.”
Thus, through the lens of the ICD-11 criteria, the COVID-19
pandemic may be viewed as a valid traumatic event, whereas
through the lens of the DSM-5, it is likely not a valid traumatic
event.
From March 2020 onward, it is reasonable to assume that
individuals throughout society may well have felt threatened
and horrified by the existential threat posed by COVID-19. We
have witnessed the inevitable and relentless global spread of
the virus from China and the corresponding deaths and illness.
There were associated and unprecedented restrictions on move-
ment (i.e., quarantine or lockdown), with devastating economic
consequences. Images of overrun hospitals, mass graves, and
COVID-19 patients being placed on assisted ventilation were
common in the media. The chance of contracting COVID-19
was (and is) a serious risk for billions of people, and for indi-
viduals over 65 years of age and those with existing medical
problems, the threat to life was (and is) very real. The possibil-
ity and reality of the loss of one’s livelihood and the associated
problems related to providing and protecting family and loved
ones was (and is) increasing. Obviously, there was (and is) also
the actual or potential threat of one’s own death or the death of
a loved one due to the disease. We contend that direct exposure
to the virus, either as a survivor or health worker in close prox-
imity to individuals with the disease, is clearly stressful and
meets the DSM-5 Criterion A definition, but we also believe
that living through the most deadly infectious respiratory dis-
ease pandemic since the 1918–1920 Spanish Flu could poten-
tially be “..extremely threatening or horrific” and, hence, meets
the guideline set in the ICD-11.
Of course, the traumatic exposure criterion is only the gate-
keeper to a potential diagnosis of PTSD; symptoms and func-
tional impairment also need to be present. Might people have
dreams or flashbacks about events related to COVID-19, such
as the potential for death, illness, or economic hardship? Might
people avoid exposure to internal or external reminders of the
pandemic? Might people be watchful or on guard in relation
to the virus? We attempted to answer these questions by ask-
ing individuals. We used the PTSD module of the International
Trauma Questionnaire (ITQ; Cloitre et al., 2018), which mea-
sures the core PTSD symptoms described in the ICD-11. It
is important to note that as we concluded that the COVID-19
pandemic was a valid traumatic event and our interest was in
measuring the effects of the pandemic on the public’s mental
health, we asked participants to complete the ITQ symptom
and functional impairment items under the following instruc-
tions: “Please answer the following questions in relation to your
experience of the COVID-19 pandemic. Please read each item
carefully, then select one of the answers to indicate how much
you have been bothered by that problem in the past month.”
We found that many of our participants did report experiences
consistent with reexperiencing in the here and now, avoidance
of traumatic reminders, and a sense of current threat, and that
these experiences were associated with functional impairment
in daily life.
One could argue of course that these responses are the re-
sult of a demand characteristic of being presented with a scale,
but this is unlikely for several reasons. First, the ITQ scores
were correlated with mental health (e.g., depression, r = .81;
generalized anxiety, r = .81; somatic problems, r = .53) and
COVID-19 related variables (e.g., perceived risk of infection, r
= .25; anxiety about the pandemic, r = .17) in a theoretically
predictable way. Second, an analysis of the latent structure of
the ITQ item scores using confirmatory factor analysis (CFA)
supported a correlated three-factor model, χ2(6, N = 1,041)
= 43.08, p < .001, RMSEA = .078, 90% CI [.06, .10], CFI
= .99, TLI = .98, SRMR = .015, and this is consistent with
a large body of evidence from previous CFAs (Brewin et al.,
2017). Finally, the endorsement of the ITQ symptomswas asso-
ciated with functional impairment (total PTSD and functional
impairment scores correlated at .70, p <.001) in very similar
ways to previous studies based on commonly accepted defi-
nitions of trauma-exposed participants (Cloitre et al., 2018).
Thus, the ITQ PTSD scores related to participants’ experience
of the COVID-19 pandemic behaved in a remarkably similar
way to ITQ scores from, for example, refugees (Vallières et al.,
2018), victims of interpersonal trauma (Hyland et al., 2017),
and institutional abuse survivors (Knefel et al., 2015).
Van Overmeire (2020) also critiqued our finding that 17.7%
of people met the diagnostic requirements for PTSD as “stag-
gering considering that in a United States–based sample,
Cloitre and colleagues (2019) found a rate of only 3.4% when
using the same PTSD scale.” Although we agree that approxi-
mately 1 in 6 people meeting the diagnostic requirements for
PTSD as assessed using a self-report scale is a high figure,
the comparison made by Van Overmeire is misguided. The fig-
ure of 3.4% reported by Cloitre et al. (2019), a study that we
coauthored, represents the rate after a differential diagnosis of
CPTSD was made. Cloitre et al. (2019) noted that 7.2% of the
participants in their sample met the diagnostic requirements for
PTSD, and, of those, 3.8% were differentially diagnosed with
CPTSD,meaning that only 3.4% retained a PTSD diagnosis. As
we noted in our paper, we assessed only the symptoms of PTSD,
which precluded our making a similar differential diagnosis. A
more apt comparison, we believe, is the one we provided in our
original paper showing that 13.2% of Irish adults met the same
PTSD requirements as those assessed using the ITQ a year ear-
lier in February 2019 (Hyland et al., 2020). It is worth noting
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that in that study, we were able to perform a differential diag-
nosis for CPTSD and found that 8.1% of the participants who
met the ITQ PTSD criteria qualified for a diagnosis of CPTSD.
Thus, although our estimated rate of COVID-19–related PTSD
(i.e., 17.7%, 95% CI [15.4%, 20.0%]) was statistically signif-
icantly higher (i.e., p < .05) than the estimated rate of PTSD
we found 1 year prior (i.e., 13.2%, 95% CI [11.2%, 15.3%]),
the result did not appear to be staggeringly out of line with ex-
isting data from the same country. Furthermore, in a trauma-
exposed, population-based sample from the United Kingdom
surveyed in 2018, Karatzias et al. (2019) found that a similar
proportion of individuals screened positive for PTSD using the
ITQ (i.e., 18.4%, 95% CI [15.9%, 20.6%]). Finally, in our par-
allel COVID-19 survey in the United Kingdom, we found that
the prevalence estimate of COVID-19–related PTSD was ex-
tremely similar to what we reported in our Irish sample (i.e.,
16.8%, 95% CI [15.2%, 18.4%]; Shevlin et al., 2020).
These are challenging, important, and difficult times for the
study of traumatic stress. We not only have to grapple with the
fact that there are differing conceptualizations of trauma-related
psychopathology, but we must also find a way to respond to
the current circumstances with compassion, integrity, and sci-
entific rigor. Not all psychological scientists will agree on the
best path forward; however, we believe that Van Overmeire’s
critique of our work, and our opportunity to reply, represents a
healthy sharing of views during this difficult time. Such debate
has been encouraged by Horesh and Brown (2020), who have
already issued a call to arms for researchers and clinicians to
address the myriad psychological issues that have arisen due to
the COVID-19 pandemic. As such, we are prepared to coun-
tenance the idea that the anticipatory threat of COVID-19 and
its consequences can be traumatic in nature for some and can
produce psychological responses consistent with PTSD.
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